ArticleCancers2022

A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer.

Jingsong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.